Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| ABIVAX Société AnonymeADS(ABVX) | 57,635 | 328,635 | +271,000 | $6.23M | $43.35M | 7.10% | +$37.12M |
| Kodiak Sciences Inc.(KOD) | 1,265,795 | 1,059,730 | -206,065 | $48.25M | $41.29M | 6.76% | -$6.97M |
| Alumis Inc | 1,213,548 | 870,548 | -343,000 | $26.73M | $24.50M | 4.01% | -$2.24M |
| Praxis Precision Medicines, Inc.(PRAX) | 71,581 | 72,842 | +1,261 | $23.06M | $24.39M | 3.99% | +$1.32M |
| Vaxcyte, Inc.(PCVX) | 428,682 | 388,682 | -40,000 | $24.91M | $22.59M | 3.70% | -$2.32M |
| ANI Pharmaceuticals, Inc.(ANIP) | 147,085 | 272,085 | +125,000 | $11.31M | $22.52M | 3.69% | +$11.21M |
| Celldex Therapeutics, Inc.(CLDX) | 461,247 | 478,500 | +17,253 | $14.63M | $17.80M | 2.91% | +$3.17M |
| Arcus Biosciences, Inc.(RCUS) | 0 | 504,559 | +504,559 | $0 | $15.56M | 2.55% | +$15.56M |
| Relmada Therapeutics, Inc.(RLMD) | 2,688,359 | 2,148,359 | -540,000 | $18.71M | $14.87M | 2.43% | -$3.84M |
| Capricor Therapeutics, Inc.(CAPR) | 528,015 | 604,215 | +76,200 | $16.05M | $14.55M | 2.38% | -$1.50M |
| Cogent Biosciences, Inc.(COGT) | 0 | 370,084 | +370,084 | $0 | $14.32M | 2.34% | +$14.32M |
| Vera Therapeutics, Inc.CL A(VERA) | 200,000 | 310,000 | +110,000 | $8.05M | $13.30M | 2.18% | +$5.26M |
| Contineum Therapeutics, Inc.CL A(CTNM) | 807,874 | 807,874 | 0 | $10.55M | $13.24M | 2.17% | +$2.69M |
| Tenax Therapeutics, Inc.(TENX) | 1,017,600 | 787,600 | -230,000 | $16.27M | $11.46M | 1.88% | -$4.81M |
| C4 Therapeutics, Inc.(CCCC) | 0 | 2,433,000 | +2,433,000 | $0 | $11.36M | 1.86% | +$11.36M |
| Maze Therapeutics, Inc.(MAZE) | 378,999 | 378,999 | 0 | $11.31M | $11.31M | 1.85% | -$3.8K |
| Biohaven Ltd.(BHVN) | 412,481 | 748,181 | +335,700 | $3.49M | $11.13M | 1.82% | +$7.64M |
| Connect Biopharma Holdings LimitedSHS(CNTB) | 5,388,486 | 4,538,534 | -849,952 | $13.12M | $10.80M | 1.77% | -$2.32M |
| Alto Neuroscience, Inc.(ANRO) | 515,000 | 407,338 | -107,662 | $11.58M | $10.75M | 1.76% | -$827.5K |
| Pharvaris N V COM | 486,856 | 308,856 | -178,000 | $13.75M | $10.68M | 1.75% | -$3.07M |
| Jade Biosciences Inc | 512,349 | 427,349 | -85,000 | $7.20M | $9.50M | 1.55% | +$2.30M |
| Damora Therapeutics, Inc.(DMRA) | 335,710 | 335,710 | 0 | $8.69M | $8.73M | 1.43% | +$36.9K |
| Viridian Therapeutics, Inc.(VRDN) | 0 | 425,000 | +425,000 | $0 | $7.81M | 1.28% | +$7.81M |
| Pelthos Therapeutics Inc.(PTHS) | 256,598 | 256,598 | 0 | $5.39M | $7.25M | 1.19% | +$1.86M |
| Zura Bio LimitedCL A(ZURA) | 1,193,492 | 1,218,492 | +25,000 | $7.10M | $7.19M | 1.18% | +$87.8K |
| Tectonic Therapeutic, Inc.(TECX) | 157,537 | 205,837 | +48,300 | $4.87M | $7.08M | 1.16% | +$2.21M |
| Spruce Biosciences Inc | 121,356 | 121,356 | 0 | $7.93M | $6.55M | 1.07% | -$1.38M |
| Hims & Hers Health, Inc.CL A(HIMS) | 0 | 188,381 | +188,381 | $0 | $6.53M | 1.07% | +$6.53M |
| Enliven Therapeutics Inc | 0 | 126,541 | +126,541 | $0 | $6.42M | 1.05% | +$6.42M |
| Proqr Thrapeutics N VSHS EURO SHS EURO | 1,492,229 | 3,425,930 | +1,933,701 | $2.42M | $6.37M | 1.04% | +$3.95M |
| Bright Minds Biosciences Inc.(DRUG) | 166,647 | 88,951 | -77,696 | $12.16M | $6.24M | 1.02% | -$5.92M |
| Ovid Therapeutics Inc.(OVID) | 2,894,704 | 2,269,704 | -625,000 | $6.43M | $6.11M | 1.00% | -$320.7K |
| Ocugen, Inc.(OCGN) | 3,962,972 | 3,962,972 | 0 | $7.17M | $6.06M | 0.99% | -$1.11M |
| Alpha Cognition Inc. Common Stock(ACOG) | 1,056,259 | 836,259 | -220,000 | $5.80M | $6.04M | 0.99% | +$238.9K |
| Harrow, Inc.(HROW) | 543,047 | 135,775 | -407,272 | $19.15M | $5.77M | 0.94% | -$13.38M |
| Kazia Therapeutics LimitedADS(KZIA) | 0 | 396,201 | +396,201 | $0 | $5.58M | 0.91% | +$5.58M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 482,571 | 165,617 | -316,954 | $10.11M | $5.53M | 0.91% | -$4.58M |
| Q32 Bio Inc.(QTTB) | 0 | 430,000 | +430,000 | $0 | $5.48M | 0.90% | +$5.48M |
| Eupraxia Pharmaceuticals Inc.(EPRX) | 1,214,741 | 809,741 | -405,000 | $8.79M | $5.35M | 0.88% | -$3.44M |
| BioAge Labs, Inc.(BIOA) | 0 | 200,000 | +200,000 | $0 | $4.90M | 0.80% | +$4.90M |
| Rezolute, Inc.(RZLT) | 16,479 | 935,012 | +918,533 | $50.3K | $4.86M | 0.80% | +$4.81M |
| Olema Pharmaceuticals, Inc.(OLMA) | 598,281 | 383,281 | -215,000 | $8.92M | $4.79M | 0.78% | -$4.13M |
| Monopar Therapeutics Inc.(MNPR) | 0 | 47,861 | +47,861 | $0 | $4.43M | 0.73% | +$4.43M |
| BridgeBio Pharma, Inc.(BBIO) | 160,120 | 57,417 | -102,703 | $11.89M | $4.28M | 0.70% | -$7.61M |
| Inventiva S.A.ADS(IVA) | 1,429,101 | 1,129,101 | -300,000 | $7.84M | $4.15M | 0.68% | -$3.69M |
| Absci Corporation | 0 | 353,772 | +353,772 | $0 | $4.10M | 0.67% | +$4.10M |
| Alector Inc | 2,082,606 | 1,982,606 | -100,000 | $4.48M | $3.99M | 0.65% | -$492.6K |
| Climb Bio, Inc.(CLYM) | 0 | 300,000 | +300,000 | $0 | $3.91M | 0.64% | +$3.91M |
| Fulcrum Therapeutics, Inc.(FULC) | 1,049,161 | 1,049,161 | 0 | $8.05M | $3.84M | 0.63% | -$4.21M |
| Cardiol Therapeutics Inc.CL A(CRDL) | 2,725,000 | 3,325,000 | +600,000 | $3.68M | $3.52M | 0.58% | -$154.3K |
| Cue Biopharma, Inc.(CUE) | 0 | 104,364 | +104,364 | $0 | $3.29M | 0.54% | +$3.29M |
| Cumberland Pharmaceuticals Inc.(CPIX) | 553,153 | 503,153 | -50,000 | $1.80M | $3.26M | 0.53% | +$1.46M |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 0 | 38,278 | +38,278 | $0 | $3.12M | 0.51% | +$3.12M |
| Rein Therapeutics Inc.(RNTX) | 0 | 2,950,000 | +2,950,000 | $0 | $3.07M | 0.50% | +$3.07M |
| Arvinas, Inc.(ARVN) | 358,257 | 358,257 | 0 | $3.80M | $2.98M | 0.49% | -$820.4K |
| Acumen Pharmaceuticals, Inc.(ABOS) | 1,053,797 | 1,053,797 | 0 | $2.49M | $2.81M | 0.46% | +$326.7K |
| ProMIS Neurosciences, Inc.(PMN) | 55,000 | 205,000 | +150,000 | $698.5K | $2.70M | 0.44% | +$2.00M |
| Annexon, Inc.(ANNX) | 580,244 | 430,244 | -150,000 | $3.21M | $2.46M | 0.40% | -$757.9K |
| Lexeo Therapeutics, Inc.(LXEO) | 513,011 | 513,011 | 0 | $2.94M | $2.39M | 0.39% | -$556.6K |
| Delcath Systems, Inc.(DCTH) | 431,251 | 185,667 | -245,584 | $4.00M | $2.34M | 0.38% | -$1.66M |
| Invivyd, Inc.(IVVD) | 2,656,570 | 2,656,570 | 0 | $3.45M | $2.32M | 0.38% | -$1.14M |
| Cabaletta Bio, Inc.(CABA) | 900,000 | 700,000 | -200,000 | $2.42M | $2.18M | 0.36% | -$244.0K |
| Neumora Therapeutics, Inc.(NMRA) | 1,278,408 | 1,278,408 | 0 | $2.49M | $2.17M | 0.36% | -$319.6K |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 0 | 117,500 | +117,500 | $0 | $2.11M | 0.35% | +$2.11M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 31,166 | 31,166 | 0 | $2.19M | $1.96M | 0.32% | -$224.7K |
| Silence Therapeutics plcADS(SLN) | 865,784 | 830,784 | -35,000 | $1.73M | $1.83M | 0.30% | +$96.2K |
| Journey Medical Corporation(DERM) | 251,436 | 251,436 | 0 | $1.18M | $1.78M | 0.29% | +$600.9K |
| DBV Technologies S.A.ADS(DBVT) | 525,000 | 525,000 | 0 | $2.20M | $1.69M | 0.28% | -$507.8K |
| iBio, Inc.(IBIO) | 957,062 | 957,062 | 0 | $1.82M | $1.67M | 0.27% | -$143.6K |
| Avalo Therapeutics, Inc.(AVTX) | 0 | 90,183 | +90,183 | $0 | $1.67M | 0.27% | +$1.67M |
| Anteris Technologies Global Corp.(AVR) | 366,571 | 166,571 | -200,000 | $2.03M | $1.64M | 0.27% | -$393.7K |
| Palisade Bio, Inc.(PALI) | 274,978 | 750,000 | +475,022 | $481.2K | $1.57M | 0.26% | +$1.09M |
| Amanat Acquisition CorpCL A | 0 | 150,000 | +150,000 | $0 | $1.52M | 0.25% | +$1.52M |
| Kalaris Therapeutics, Inc.(KLRS) | 360,000 | 360,000 | 0 | $2.08M | $1.47M | 0.24% | -$612.0K |
| Quince Therapeutics Inc | 0 | 72,251 | +72,251 | $0 | $1.31M | 0.22% | +$1.31M |
| Lipocine Inc.(LPCN) | 508,556 | 508,556 | 0 | $4.06M | $1.30M | 0.21% | -$2.76M |
| Immunome, Inc.(IMNM) | 0 | 60,000 | +60,000 | $0 | $1.27M | 0.21% | +$1.27M |
| Pliant Therapeutics, Inc.(PLRX) | 0 | 1,000,000 | +1,000,000 | $0 | $1.14M | 0.19% | +$1.14M |
| Immunic, Inc.(IMUX) | 0 | 67,464 | +67,464 | $0 | $1.04M | 0.17% | +$1.04M |
| Quoin Pharmaceuticals, Ltd.ADS(QNRX) | 211,538 | 211,538 | 0 | $1.40M | $1.02M | 0.17% | -$372.3K |
| Equillium, Inc.(EQ) | 303,555 | 303,555 | 0 | $607.1K | $971.4K | 0.16% | +$364.3K |
| Neuronetics, Inc.(STIM) | 701,182 | 701,182 | 0 | $1.02M | $911.5K | 0.15% | -$105.2K |
| Faeth Therapeutics, Inc.(FTH) | 6,351 | 35,386 | +29,035 | $200.2K | $884.6K | 0.14% | +$684.5K |
| Fractyl Health, Inc.(GUTS) | 1,100,000 | 1,100,000 | 0 | $503.6K | $873.8K | 0.14% | +$370.3K |
| Cybin D/B/A Helus Pharma(HELP) | 132,153 | 132,153 | 0 | $634.3K | $873.5K | 0.14% | +$239.2K |
| First Tracks Biotherapeutics | 0 | 42,775 | +42,775 | $0 | $860.6K | 0.14% | +$860.6K |
| Verastem, Inc.(VSTM) | 213,865 | 213,865 | 0 | $1.13M | $817.0K | 0.13% | -$316.5K |
| Direxion Shares Etf TrustDAI BIO BEA ETF DAI BIO BEA ETF | 105,822 | 105,822 | 0 | $1.72M | $815.9K | 0.13% | -$909.0K |
| PepGen Inc.(PEPG) | 447,165 | 447,165 | 0 | $791.5K | $804.9K | 0.13% | +$13.4K |
| Acadia Pharmaceuticals Inc | 28,099 | 28,099 | 0 | $625.5K | $710.9K | 0.12% | +$85.4K |
| CNS Pharmaceuticals, Inc.(CNSP) | 45,830 | 135,830 | +90,000 | $110.0K | $649.3K | 0.11% | +$539.3K |
| Lyell Immunopharma, Inc.(LYEL) | 41,081 | 41,081 | 0 | $824.1K | $577.2K | 0.09% | -$246.9K |
| Wave Life Sciences, Inc.SHS(WVE) | 85,285 | 85,285 | 0 | $618.3K | $495.5K | 0.08% | -$122.8K |
| Immatics N.V.SHS(IMTX) | 48,569 | 48,569 | 0 | $477.9K | $492.0K | 0.08% | +$14.1K |
| Passage Bio, Inc.(PASG) | 68,124 | 99,517 | +31,393 | $534.8K | $485.6K | 0.08% | -$49.1K |
| Nextcure Inc | 238,303 | 288,303 | +50,000 | $2.51M | $461.3K | 0.08% | -$2.05M |
| Forte Biosciences Inc | 118,972 | 20,972 | -98,000 | $3.08M | $445.7K | 0.07% | -$2.64M |
| Solid Biosciences Inc | 264,409 | 42,956 | -221,453 | $1.90M | $429.1K | 0.07% | -$1.47M |
| Traws Pharma, Inc.(TRAW) | 678,142 | 478,142 | -200,000 | $1.24M | $403.2K | 0.07% | -$837.8K |
| Lexicon Pharmaceuticals, Inc.(LXRX) | 164,674 | 164,674 | 0 | $256.9K | $395.2K | 0.06% | +$138.3K |